In CAL-27 tongue carcinoma cells, FLI-06 reduced CCK8 viability in a concentration-dependent manner. The reported approximate IC50 range was 4.24–5.26 µM across 48- and 72-hour exposures; the source does not assign the individual values to each time point in its text. This viability endpoint does not establish Notch-specific cytotoxicity. [2]
Inhibition of GPI-anchored reporter transport
Cell-based study · HeLa cells transiently expressing YFP-GPI [1]
FLI-06 inhibited surface transport of the GPI-anchored reporter relative to DMSO. Brefeldin A provided a secretion-blocking comparator.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Exposure duration
- 18 h
- Method
- Immunofluorescence microscopy after compound exposure and fixation
- Vehicle
- DMSO control
- Reported limits
- Vehicle percentage and full main-text cell-handling methods were not retrieved.
Methods and source locations
Compound reported in the paper: FLI-06; Compound label in the paper: FLI-06 (1)
Evidence concerns the paper’s tested FLI-06 material; it does not validate an Adooq lot or establish equivalence of stereochemical composition.
Supplementary Figure 10a and caption, PDF p. 11; Table 4, p. 21; Supplementary Notes/Table 5, p. 22
Surface transport of YFP-GPI: Immunofluorescence microscopy — Supplementary Figure 10a and caption, PDF p. 11
Rapid inhibition of cargo concentration at ER exit sites
Cell-based study · HeLa cells transiently expressing VSVG-EGFP, analyzed under a temperature-shift transport assay with nocodazole [1]
FLI-06 suppressed cargo concentration and subsequent ER export even when introduced only at the start of the chase. This supports rapid interference with the early secretory pathway.
Literature-Reported Treatment Conditions
- Exposure duration
- Chase endpoints 0, 30 and 85 min; pretreatment 30 min, 10 min, or none
- Method
- Fluorescence microscopy; variance of pixel fluorescence intensity in regions of interest
- Vehicle
- DMSO control
- Reported limits
- FLI-06 concentration is not stated in the Figure 11 caption; main-text methods were not retrieved. No concentration is borrowed from Figure 10.
Methods and source locations
Compound reported in the paper: FLI-06; Compound label in the paper: FLI-06 (1)
Evidence concerns the paper’s tested FLI-06 material; it does not validate an Adooq lot or establish equivalence of stereochemical composition.
Supplementary Figure 11 and caption, PDF p. 12; Table 4, p. 21; Supplementary Notes/Table 5, p. 22
Concentration of VSVG-EGFP at ER exit sites and subsequent ER export: Variance of pixel fluorescence intensity; at least 15 cells/condition/experiment — Supplementary Figure 11 and caption, PDF p. 12
CAL-27 concentration-response viability assay
Cell-based study · Human CAL-27 tongue squamous carcinoma cells [2]
CCK8 assays showed a concentration-dependent response after 48 or 72 h. The authors report an approximate CAL-27 IC50 range across these time points.
Literature-Reported Treatment Conditions
- Treatment concentration
- 2–10 µM shown in Figure 2A
- Exposure duration
- 48 or 72 h
- Method
- CCK8 cell viability assay
- Reported limits
- Cellular vehicle concentration and per-time-point fitted IC50 values are not supplied in the adopted text; no fitted values are inferred from curves.
Methods and source locations
Compound reported in the paper: FLI-06; Compound label in the paper: FLI-06
Evidence concerns the paper’s tested FLI-06 material; it does not validate an Adooq lot or establish equivalence of stereochemical composition.
Results: The Notch Signaling Pathway Inhibitor Restrains Tongue Cancer Cell Proliferation In Vitro; Figure 2A and caption; Methods: Cell Lines And Cell Cultures, Cell Proliferation Assay
CAL-27 viability after 48 or 72 h: CCK8; reported range across two time points, not a treatment dose — Results: The Notch Signaling Pathway Inhibitor Restrains Tongue Cancer Cell Proliferation In Vitro, paragraph 1; Figure 2A